Picture of Abbott Laboratories logo

ABT — Abbott Laboratories Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Abbott Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue
Cost of Revenue
Gross Profit
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses
Operating Profit
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Net Income Before Extraordinary Items
Extraordinary Items
Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS
Dividends per Share

Or unlock with your email

Or unlock with your email